These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25086050)

  • 1. "First-wave" bias when conducting active safety monitoring of newly marketed medications with outcome-indexed self-controlled designs.
    Wang SV; Schneeweiss S; Maclure M; Gagne JJ
    Am J Epidemiol; 2014 Sep; 180(6):636-44. PubMed ID: 25086050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Future cases as present controls to adjust for exposure trend bias in case-only studies.
    Wang S; Linkletter C; Maclure M; Dore D; Mor V; Buka S; Wellenius GA
    Epidemiology; 2011 Jul; 22(4):568-74. PubMed ID: 21577117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When should case-only designs be used for safety monitoring of medical products?
    Maclure M; Fireman B; Nelson JC; Hua W; Shoaibi A; Paredes A; Madigan D
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():50-61. PubMed ID: 22262593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Different Case-Crossover Variants in Handling Exposure-Time Trend or Persistent-User Bias: Using Dipeptidyl Peptidase-4 Inhibitors and the Risk of Heart Failure as an Example.
    Dong YH; Wang SV; Gagne JJ; Wu LC; Chang CH
    Value Health; 2020 Feb; 23(2):217-226. PubMed ID: 32113627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bias in case-crossover studies of medications due to persistent use: A simulation study.
    Bykov K; Wang SV; Hallas J; Pottegård A; Maclure M; Gagne JJ
    Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1079-1085. PubMed ID: 32548875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leveraging the entire cohort in drug safety monitoring: part 1 methods for sequential surveillance that use regression adjustment or weighting to control confounding in a multisite, rare event, distributed data setting.
    Nelson JC; Ulloa-Pérez E; Bobb JF; Maro JC
    J Clin Epidemiol; 2019 Aug; 112():77-86. PubMed ID: 31108199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active safety monitoring of newly marketed medications in a distributed data network: application of a semi-automated monitoring system.
    Gagne JJ; Glynn RJ; Rassen JA; Walker AM; Daniel GW; Sridhar G; Schneeweiss S
    Clin Pharmacol Ther; 2012 Jul; 92(1):80-6. PubMed ID: 22588606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aripiprazole and acute dystonia].
    Komen G; Van Den Eede F; Dom G
    Tijdschr Psychiatr; 2009; 51(10):761-5. PubMed ID: 19821245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symmetry analysis for monitoring safety of newly marketed drugs.
    Kubota K
    Pharmacoepidemiol Drug Saf; 2016 Mar; 25(3):349-51. PubMed ID: 26440748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case-crossover studies of therapeutics: design approaches to addressing time-varying prognosis in elderly populations.
    Wang SV; Gagne JJ; Glynn RJ; Schneeweiss S
    Epidemiology; 2013 May; 24(3):375-8. PubMed ID: 23466528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Publication bias in antipsychotic trials: an analysis of efficacy comparing the published literature to the US Food and Drug Administration database.
    Turner EH; Knoepflmacher D; Shapley L
    PLoS Med; 2012; 9(3):e1001189. PubMed ID: 22448149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of acute liver injury among users of antibiotic medications: a comparison of case-only studies.
    Brauer R; Ruigómez A; Klungel O; Reynolds R; Feudjo Tepie M; Smeeth L; Douglas I
    Pharmacoepidemiol Drug Saf; 2016 Mar; 25 Suppl 1(Suppl Suppl 1):39-46. PubMed ID: 26248609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the use of methods to mitigate bias from non-transient medications in the case-crossover design: A systematic review.
    Huang HC; Li WC; Tadrous M; Schumock GT; Touchette D; Awadalla S; Lee TA
    Pharmacoepidemiol Drug Saf; 2023 Sep; 32(9):939-950. PubMed ID: 37283212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An empirical assessment of immeasurable time bias in the setting of nested case-control studies: Statins and all-cause mortality among patients with heart failure.
    Oh IS; Filion KB; Jeong HE; Shin JY
    Pharmacoepidemiol Drug Saf; 2019 Oct; 28(10):1318-1327. PubMed ID: 31432599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Within-person study designs had lower precision and greater susceptibility to bias because of trends in exposure than cohort and nested case-control designs.
    Nicholas JM; Grieve AP; Gulliford MC
    J Clin Epidemiol; 2012 Apr; 65(4):384-93. PubMed ID: 22197519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The withdrawal of rofecoxib.
    Arellano FM
    Pharmacoepidemiol Drug Saf; 2005 Mar; 14(3):213-7. PubMed ID: 15724267
    [No Abstract]   [Full Text] [Related]  

  • 19. Parecoxib, valdecoxib, and cardiovascular risk.
    Furberg CD; Psaty BM; FitzGerald GA
    Circulation; 2005 Jan; 111(3):249. PubMed ID: 15655125
    [No Abstract]   [Full Text] [Related]  

  • 20. Psychosocial functioning in patients with schizophrenia treated with aripiprazole - an office-based real-world setting. Results from the German post-marketing surveillance study.
    Bergmann F; Zacher A; Nass A; Urban R; Werner C; Spevakné-Göröcs T; Kungel M; Ebrecht M; Modell S
    Pharmacopsychiatry; 2009 May; 42(3):101-8. PubMed ID: 19452378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.